Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

• Cancer Immunoprevention Network (CIP-Net)
• Cancer Prevention Clinical Trials Network (CP-CTNet)
• Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
• Discovery and Development of Natural Products for Cancer Interception and Prevention (DDNP-CIP)
• PREVENT Cancer Preclinical Drug Development Program (PREVENT)